You are here

Boundless Bio

Sluggish enrollment leads Boundless Bio to make 'modest' layoffs 5 months after $100M IPO

Fierce Biotech

Tue, 08/13/24 - 11:32 am

clinical trials

Biopharma IPOs From the First Half of 2024

BioSpace

Thu, 05/30/24 - 11:17 am

Kyverna Therapeutics

ArriVent Biopharma

Alto Neuroscience

Contineum Therapeutics

Rapport Therapeutics

Telix Pharmaceuticals

Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24

Fierce Biotech

Wed, 04/3/24 - 11:36 am

Kyverna Therapeutics

Contineum Therapeutics

CymaBay Therapeutics

Gilead Sciences

Fusion Pharmaceuticals

Boundless Bio breaks IPO lull with $100M fundraise

BioPharma Dive

Wed, 03/27/24 - 10:37 pm

Arch Venture Partners

Boundless Bio eyes $88M offering as spring biotech IPO market blooms

Fierce Biotech

Thu, 03/21/24 - 11:32 am

Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO

BioPharma Dive

Thu, 03/7/24 - 11:13 am

Arch Venture Partners

Startup Boundless Bio brings in $105M to break the circle behind cancer growth

MedCity News

Wed, 04/28/21 - 09:56 pm

'A fourth revolution in cancer therapies': ARCH-backed Boundless Bio flashes big check, makes bigger promises in debut

Endpoints

Thu, 09/19/19 - 10:04 am